Search Result "D2 PA"
D2 Receptor Partial Agonists: Treatment of CNS Disorders of Dopamine Function
Journal: Current Topics in Medicinal Chemistry
Volume: 8 Issue: 1 Year: 2008 Page: 1068-1088
Author(s): John H. Kehne, Terrance H. Andree, Julia N. Heinrich
Neurotensin NTS1-Dopamine D2 Receptor-Receptor Interactions in Putative Receptor Heteromers: Relevance for Parkinson`s Disease and Schizophrenia
Journal: Current Protein & Peptide Science
Volume: 15 Issue: 7 Year: 2014 Page: 681-690
Author(s): Luca Ferraro,Sarah Beggiato,Dasiel O. Borroto-Escuela,Laura Ravani,William T. O'Connor,Maria C. Tomasini,Andrea C. Borelli,Luigi F. Agnati,Tiziana Antonelli,Sergio Tanganelli,Kjell Fuxe
Relevance of Dopamine D2/Neurotensin NTS1 and NMDA/Neurotensin NTS1 Receptor Interaction in Psychiatric and Neurodegenerative Disorders
Journal: Current Medicinal Chemistry
Volume: 19 Issue: 3 Year: 2012 Page: 304-316
Author(s): S. Tanganelli, T. Antonelli, M. C. Tomasini, S. Beggiato, K. Fuxe, L. Ferraro
Novel Approaches in the Treatment of Antipsychotic-Induced Hyperprolactinemia:The Role of Partial Agonists of D2 Dopaminergic Receptors
Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 4 Issue: 3 Year: 2010 Page: 230-240
Author(s): Domenico De Berardis, Tiziano Acciavatti, Daniela Campanella, Nicola Serroni, Luigi Olivieri, Carla Ranalli, Viviana Marasco, Alessandro Carano, Marilde Cavuto, Giuseppe Di Iorio, Monica Piersanti, Francesco S. Moschetta, Massimo Di Giannantonio
Dopamine Receptor Interacting Proteins: Targeting Neuronal Calcium Sensor-1/D2 Dopamine Receptor Interaction for Antipsychotic Drug Development
Journal: Current Drug Targets
Volume: 13 Issue: 1 Year: 2012 Page: 72-79
Author(s): Nadine Kabbani, Mathew P. Woll, Jacob C. Nordman, Robert Levenson
Treatment of Antipsychotic-Induced Hyperprolactinemia: An Update on the Role of the Dopaminergic Receptors D2 Partial Agonist Aripiprazole
Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 8 Issue: 1 Year: 2014 Page: 30-37
Author(s): Domenico De Berardis,Michele Fornaro,Nicola Serroni,Stefano Marini,Monica Piersanti,Marilde Cavuto,Alessandro Valchera,Monica Mazza,Gabriella Girinelli,Felice Iasevoli,Giampaolo Perna,Giovanni Martinotti,Massimo Di Giannantonio
Conditioned Avoidance Response in the Development of New Antipsychotics
Journal: Current Pharmaceutical Design
Volume: 16 Issue: 3 Year: 2010 Page: 358-370
Author(s): M-L. G. Wadenberg
Current Strategies for the Development of Novel Antipsychotic Drugs
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 3 Issue: 3 Year: 2003 Page: 239-251
Author(s): Jordi Bolos
Antipsychotic Drugs: Evolving Mechanisms of Action with Improved Therapeutic Benefits
Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 3 Issue: 3 Year: 2004 Page: 217-226
Author(s): B. Dean, E. Scarr
Novel Targets for Drugs in Schizophrenia
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 6 Issue: 4 Year: 2007 Page: 265-272
Author(s): J.M. Stone, L.S. Pilowsky